The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Air Force Releasing SI Literacy Plan for Airmen, Guardians
Chief Data and AI Officer Susan Davenport said the training is part of its effort to define how the department will use SI across 15 domains.
3m read -
Cyberattacks on Military Bases Expose Critical Infrastructure Security Gaps
Recent attacks on refrigeration systems highlight persistent IT/OT vulnerabilities as federal agencies call for stronger safeguards.
3m read -
VA, DOW Join TEFCA to Expand Nationwide Health Data Exchange
VA and DOW join TEFCA, expanding secure health information sharing for veterans, service members and providers.
2m read -
Federal Health Leaders Explore Guardrails for AI
NIH, NCI and industry leaders discuss AI governance, data security and safeguards for deploying AI in federal health systems.
37m watch Partner Content
